Sep 14, 2015 - Mylan NV continues aggressive bid for fellow generic drug maker Perrigo with a tender offer to shareholders.
Sep 11, 2015 - Aduro (ADRO) signed a clinical study agreement with Incyte (INCY) to evaluate CRS-207, in combination with Incyte's epacadostat, in patients with ovarian cancer.
Sep 07, 2015 - Novartis' (NVS) Farydak (plus Velcade and dexamethasone) gets EU approval for relapsed and/or refractory multiple myeloma in treatment-experienced patients.
Sep 03, 2015 - Novartis (NVS) launched Zarxio (biosimilar version of Amgen's Neupogen) in the U.S., which became the first FDA-approved biosimilar to be launched in the country.
Sep 02, 2015 - Amgen (AMGN) inks deal with Novartis for Alzheimer's disease and migraine; reports positive phase III data on romosozumab.
Aug 28, 2015 - Pfizer (PFE) commenced a phase III study (PALLAS) on Ibrance in early-stage breast cancer patients.
Aug 26, 2015 - Novartis (NVS) with partner Ligand (LGND) announced that the FDA has approved the use of Promacta in children between 1 to 6 years of age with chronic ITP.
Aug 26, 2015 - Euronav NV in the Shipping Transportation industry could be a great candidate for another beat as recent estimates have been moving higher for the company, while the Earnings ESP for EURN is positive, which is a great sign of a coming beat.
Aug 24, 2015 - Novartis (NVS) inked a deal with GlaxoSmithKline to acquire all remaining rights to Arzerra for up to $1 billion plus royalties.
Apr 26, 2012 - QUAD GRAPHICS